Drawing for TRANSFILM

USPTO serial 79112545

TRANSFILM

Reviewed by CopyMark Law Group

Reg. 4315319Status 706Registered
Filing date
Status date
Registration date
Apr 9, 2013
Examiner
WILLIS, PAMELA Y
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with TRANSFILM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Leigh Ann Lindquist

LEIGH ANN LINDQUIST Sughrue Mion, PLLC2000 PENNSYLVANIA AVENUE NW, SUITE 9000Washington, DC 20006UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005[ Pharmaceutical and veterinary preparations and products for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, neurodegenerative disorders, infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders, cancer, allergies, migraine; sanitary products for medical purposes; pharmaceutical products in form of self-adhesive preparations for medical purposes, in particular patches for local application of pharmaceutical substances; carrier substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical products, namely, drug delivery agents in form of polymer-based transdermal patches, topical patches, namely, patch-like substance carriers to deliver locally active drugs to a local site of action, buccal patches, namely, patch-like substance carriers to deliver drugs through the buccal mucosa and through the gingival and oral dissolvable films that provide controlled release of the active ingredients for a wide variety of pharmaceuticals ]SECTION 7(e) - CANCELLED
040Custom manufacture of pharmaceutical and veterinary products for third parties, in particular of self-adhesive compositions for medical purposes, in particular patches for local application of pharmaceutical substancesACTIVE
042Research, development as well as technological consulting in the field of pharmacy, pharmacology, biotechnology or chemistry, all in particular in the field of active substances containing self-adhesive compositions; analysis and evaluation of product development in particular of the self-adhesive active substances containing compositionsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Apr 28, 2025INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Feb 12, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 12, 2024NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jun 12, 202471AGREGISTERED-SEC.71 ACCEPTED
May 28, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Oct 2, 2023ES71TEAS SECTION 71 RECEIVED
Mar 1, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 1, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 1, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 1, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 1, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 1, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 17, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 3, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 7, 2022INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Oct 14, 2022INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Feb 15, 2022LIMELIMITATION FROM THE IB EXAMINED AND ENTERED
Feb 14, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 14, 2022COC.CORRECTION UNDER SECTION 7 - PROCESSED
Feb 14, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 20, 2022RNWLINTERNATIONAL REGISTRATION RENEWED
Dec 25, 2021LIMGLIMITATION OF GOODS RECEIVED FROM IB
May 6, 2019NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - MAILED
May 6, 2019C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 24, 2019APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 5, 2019TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 5, 2019ES75TEAS SECTION 71 & 15 RECEIVED
Mar 28, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 9, 2018REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 27, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Jul 11, 2013FICSFINAL DISPOSITION NOTICE SENT TO IB
Jul 11, 2013FIMPFINAL DISPOSITION PROCESSED
Jul 9, 2013FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 9, 2013R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 5, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 20, 2013GPNXNOTIFICATION PROCESSED BY IB
Jan 22, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 22, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 2, 2013OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 2, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 2, 2013OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 17, 2012PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 14, 2012ALIEASSIGNED TO LIE
Dec 1, 2012CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Nov 30, 2012TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2012CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2012TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2012ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 18, 2012REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 25, 2012RFNPREFUSAL PROCESSED BY IB
Jun 2, 2012MAFRAPPLICATION FILING RECEIPT MAILED
Jun 1, 2012RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 1, 2012RFRRREFUSAL PROCESSED BY MPU
Jun 1, 2012RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 31, 2012CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 29, 2012DOCKASSIGNED TO EXAMINER
May 29, 2012NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2012REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance